Setting

North America Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

Published: 30 Apr 2023 | Report Code: 10248389 | Pages: 197

North America Active Pharmaceutical Ingredients (API) Market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in the geriatric population. Highlighted with 82 tables and 75 figures, this 197-page report “North America Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America Active Pharmaceutical Ingredients (API) Market and all its sub-segments through extensively detailed classifications.

 

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include the identification and investigation of the following aspects:
•  Market Structure 
•  Growth Drivers 
•  Restraints and Challenges
•  Emerging Product Trends & Market Opportunities
•  Porter’s Five Forces

 

The trend and outlook of North America market is forecast in an optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Active Pharmaceutical Ingredients (API) Market in every aspect of the classification from perspectives of Molecule, Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

 

Based on Molecule, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Small Molecule APIs
•  Large Molecule APIs

 

Based on Synthesis, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Synthetic API
    o  Branded Synthetic API
    o  Generic Synthetic API
•  Biotech API
    o  By Type 
        o  Monoclonal Antibodies
        o  Recombinant Proteins
        o  Vaccines
        o  Other Biotech APIs
    o  By Category 
        o  Innovative Biologic API
        o  Generic Biosimilar API
    o  By Expression 
        o  Mammalian Expression
        o  Microbial Expression
        o  Yeast Expression
        o  Insect Expression
        o  Other Expression Technologies
•  HPAPI
    o  Branded HPAPI
    o  Generic HPAPI

 

Based on Manufacturing Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Captive Manufacturing
    o  Branded Captive API
    o  Generic Captive API
•  Merchant Manufacturing
    o  By Drug Type 
        o  Branded Merchant API
        o  Generic Merchant API
    o  By Drug Synthesis 
        o  Merchant Synthetic API
        o  Merchant Biotech API

 

By Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Infectious Diseases
•  Oncology
•  Ophthalmology 
•  Cardiovascular Disorders
•  Central Nervous System
•  Pulmonary Disorders
•  Orthopedics
•  Other Applications

 

By Drug Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. 
•  Branded Prescription Drugs
•  Generic Prescription Drugs
•  OTC Drugs

 

Geographically, the following national/local markets are fully investigated:
•  U.S.
•  Canada
•  Mexico 

 

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included. The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

 

Selected Key Players: 
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:

1.1 Industry Definition and Research Scope    9
1.1.1 Industry Definition    9
1.1.2 Research Scope    10
1.2 Research Methodology    13
1.2.1 Overview of Market Research Methodology    13
1.2.2 Market Assumption    14
1.2.3 Secondary Data    14
1.2.4 Primary Data    14
1.2.5 Data Filtration and Model Design    15
1.2.6 Market Size/Share Estimation    16
1.2.7 Research Limitations    17
1.3 Executive Summary    18
2 Market Overview and Dynamics    21
2.1 Market Size and Forecast    21
2.1.1 Impact of COVID-19 on World Economy    22
2.1.2 Impact of COVID-19 on the Market    25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery    32
2.2 Major Growth Drivers    36
2.3 Market Restraints and Challenges    44
2.4 Emerging Opportunities and Market Trends    47
2.5 Porter’s Fiver Forces Analysis    51
3 Segmentation of North America Market by Molecule    55
3.1 Market Overview by Molecule    55
3.2 Small Molecule APIs    57
3.3 Large Molecule APIs    58
4 Segmentation of North America Market by Synthesis    59
4.1 Market Overview by Synthesis    59
4.2 Synthetic API    61
4.2.1 Branded Synthetic API    62
4.2.2 Generic Synthetic API    63
4.3 Biotech API    64
4.3.1 Biotech API by Drug Type    65
4.3.1.1 Monoclonal Antibodies    66
4.3.1.2 Recombinant Proteins    67
4.3.1.3 Vaccines    68
4.3.1.4 Other Biotech APIs    69
4.3.2 Biotech API by Category    70
4.3.2.1 Innovative Biologic API    71
4.3.2.2 Generic Biosimilar API    72
4.3.3 Biotech API by Expression Technology    73
4.3.3.1 Mammalian Expression    74
4.3.3.2 Microbial Expression    75
4.3.3.3 Yeast Expression    76
4.3.3.4 Insect Expression    77
4.3.3.5 Other Expression Technologies    78
4.4 HPAPI    79
4.4.1 Branded HPAPI    80
4.4.2 Generic HPAPI    81
5 Segmentation of North America Market by Manufacturing Process    82
5.1 Market Overview by Manufacturing Process    82
5.2 Captive Manufacturing    84
5.2.1 Branded Captive API    85
5.2.2 Generic Captive API    86
5.3 Merchant Manufacturing    87
5.3.1 Merchant Manufacturing by Drug Type    88
5.3.1.1 Branded Merchant API    89
5.3.1.2 Generic Merchant API    90
5.3.2 Merchant Manufacturing by Drug Synthesis    91
5.3.2.1 Merchant Synthetic API    92
5.3.2.2 Merchant Biotech API    93
6 Segmentation of North America Market by Therapeutic Application    94
6.1 Market Overview by Therapeutic Application    94
6.2 Infectious Diseases    96
6.3 Oncology    97
6.4 Ophthalmology    98
6.5 Cardiovascular Disorders    99
6.6 Central Nervous System    100
6.7 Pulmonary Disorders    101
6.8 Orthopedics    102
6.9 Other Applications    103
7 Segmentation of North America Market by Drug Type    104
7.1 Market Overview by Drug Type    104
7.2 Branded Prescription Drugs    106
7.3 Generic Prescription Drugs    107
7.4 OTC Drugs    108
8 North America Market 2022-2032 by Country    109
8.1 Overview of North America Market    109
8.2 U.S.    112
8.3 Canada    122
8.4 Mexico    124
9 Competitive Landscape    126
9.1 Overview of Key Vendors    126
9.2 New Product Launch, Partnership, Investment, and M&A    129
9.3 Company Profiles    130
AbbVie Inc.    130
Astrazeneca    132
Aurobindo Pharma Ltd.    137
BASF    140
Bayer AG    143
Boehringer Ingelheim    147
Catalent Inc.    152
Dr. Reddy's Laboratories    155
F. Hoffmann-La Roche    157
GlaxoSmithKline plc    160
Lonza Group    165
Lupin Limited    169
Merck & Co., Inc.    172
Mylan NV    175
Novartis International AG    178
Pfizer Inc.    181
Sanofi    186
Sun Pharmaceutical Industries Ltd.    189
Teva Pharmaceutical Industries Ltd.    192
Thermo Fisher Scientific    194
Related Reports and Products    197

 

List of Tables:

Table 1. Snapshot of North America Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032    19
Table 2. World Economic Outlook, 2021-2031    23
Table 3. World Economic Outlook, 2021-2023    24
Table 4. Scenarios for Economic Impact of Ukraine Crisis    33
Table 5. World Health Spending by Region, $ bn, 2013-2020    42
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn    43
Table 7. Main Product Trends and Market Opportunities in North America Active Pharmaceutical Ingredients (API) Market    47
Table 8. North America Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn    55
Table 9. North America Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    59
Table 10. North America Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn    61
Table 11. North America Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn    65
Table 12. North America Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn    70
Table 13. North America Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn    73
Table 14. North America Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn    79
Table 15. North America Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    82
Table 16. North America Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn    84
Table 17. North America Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn    88
Table 18. North America Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn    91
Table 19. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    94
Table 20. North America Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn    104
Table 21. North America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn    110
Table 22. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    114
Table 23. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    114
Table 24. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    114
Table 25. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, ?sed on Dollar Value    116
Table 26. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    123
Table 27. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    123
Table 28. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    123
Table 29. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn    125
Table 30. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn    125
Table 31. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn    125
Table 32. AbbVie Inc.: Company Snapshot    130
Table 33. AbbVie Inc.: Business Segmentation    131
Table 34. AbbVie Inc.: Product Portfolio    131
Table 35. Astrazeneca: Company Snapshot    132
Table 36. Aurobindo Pharma Ltd.: Company Snapshot    137
Table 37. Aurobindo Pharma Ltd.: Product Portfolio    138
Table 38. BASF: Company Snapshot    140
Table 39. BASF: Business Segmentation    141
Table 40. Bayer AG: Company Snapshot    143
Table 41. Bayer AG: Business Segmentation    144
Table 42. Bayer AG: Product Portfolio    144
Table 43. Boehringer Ingelheim: Company Snapshot    147
Table 44. Boehringer Ingelheim: Product Portfolio    148
Table 45. Catalent Inc.: Company Snapshot    152
Table 46. Catalent Inc.: Business Segmentation    153
Table 47. Catalent Inc.: Product Portfolio    153
Table 48. Dr. Reddy's Laboratories: Company Snapshot    155
Table 49. Dr. Reddy's Laboratories: Business Segmentation    155
Table 50. F. Hoffmann-La Roche: Company Snapshot    157
Table 51. F. Hoffmann-La Roche: Clinical Trial Service    157
Table 52. F. Hoffmann-La Roche: Business Segmentation    158
Table 53. F. Hoffmann-La Roche: Revenue by Region    158
Table 54. GlaxoSmithKline: Company Snapshot    160
Table 55. GlaxoSmithKline: Business Segmentation    161
Table 56. GlaxoSmithKline: Product Portfolio    162
Table 57. Lonza Group: Company Snapshot    165
Table 58. Lonza Group: Business Segmentation    166
Table 59. Lonza Group: Product Portfolio    166
Table 60. Lupin Limited: Company Snapshot    169
Table 61. Lupin Limited: Business Segmentation    170
Table 62. Merck & Co., Inc.: Company Snapshot    172
Table 63. Merck & Co., Inc.: Business Segmentation    173
Table 64. Mylan NV: Company Snapshot    175
Table 65. Mylan NV: Breakdown of Revenue by Region, 2022    176
Table 66. Mylan NV: Breakdown of Revenue by Product Category, 2022    176
Table 67. Novartis International AG: Company Snapshot    178
Table 68. Novartis International AG: Business Segmentation    179
Table 69. Pfizer Inc.: Company Snapshot    181
Table 70. Pfizer Inc.: Business Segmentation    182
Table 71. Pfizer Inc.: Breakdown of Revenue by Product Category    182
Table 72. Pfizer Inc.: Breakdown of Revenue by Region    183
Table 73. Pfizer Inc.: Product Portfolio    183
Table 74. Sanofi: Company Snapshot    186
Table 75. Sanofi: Business Segmentation    187
Table 76. Sanofi: Breakdown of Revenue by Region    187
Table 77. Sun Pharmaceutical Industries Limited: Company Snapshot    189
Table 78. Teva Pharmaceutical Industries Ltd.: Company Snapshot    192
Table 79. Teva Pharmaceutical Industries Ltd.: Business Segmentation    193
Table 80. Thermo Fisher Scientific: Company Snapshot    194
Table 81. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, 5
Table 82. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, 5

 

List of Figures:

Figure 1. Research Method Flow Chart    13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation    16
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032    18
Figure 4. North America Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    21
Figure 5. Impact of COVID-19 on Business    25
Figure 6. Primary Drivers and Impact Factors of North America Active Pharmaceutical Ingredients (API) Market    36
Figure 7. GDP per capita in the World, 1960-2022, $ thousand    39
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million    40
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million    41
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060    41
Figure 11. Primary Restraints and Impact Factors of North America Active Pharmaceutical Ingredients (API) Market    44
Figure 12. Investment Opportunity Analysis    48
Figure 13. Porter’s Fiver Forces Analysis of North America Active Pharmaceutical Ingredients (API) Market    51
Figure 14. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue    56
Figure 15. North America Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%)    56
Figure 16. North America Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn    57
Figure 17. North America Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn    58
Figure 18. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue    59
Figure 19. Contribution to North America 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)    60
Figure 20. North America Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn    61
Figure 21. North America Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn    62
Figure 22. North America Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn    63
Figure 23. North America Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn    64
Figure 24. North America Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn    66
Figure 25. North America Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn    67
Figure 26. North America Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn    68
Figure 27. North America Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn    69
Figure 28. North America Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn    71
Figure 29. North America Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn    72
Figure 30. North America Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn    74
Figure 31. North America Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn    75
Figure 32. North America Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn    76
Figure 33. North America Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn    77
Figure 34. North America Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn    78
Figure 35. North America Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn    79
Figure 36. North America Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn    80
Figure 37. North America Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn    81
Figure 38. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue    82
Figure 39. Contribution to North America 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)    83
Figure 40. North America Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn    84
Figure 41. North America Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn    85
Figure 42. North America Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn    86
Figure 43. North America Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn    87
Figure 44. North America API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn    89
Figure 45. North America API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn    90
Figure 46. North America API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn    92
Figure 47. North America API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn    93
Figure 48. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue    94
Figure 49. Contribution to North America 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)    95
Figure 50. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn    96
Figure 51. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn    97
Figure 52. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn    98
Figure 53. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn    99
Figure 54. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn    100
Figure 55. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn    101
Figure 56. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn    102
Figure 57. North America Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn    103
Figure 58. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue    104
Figure 59. Contribution to North America 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)    105
Figure 60. North America Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn    106
Figure 61. North America Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn    107
Figure 62. North America Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn    108
Figure 63. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue    110
Figure 64. Contribution to North America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)    111
Figure 65. U.S. Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    113
Figure 66. Manufacturing Sites of APIs for U.S. Market by Country or Region,    118
Figure 67. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List    118
Figure 68.  Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List    119
Figure 69. Canada Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn    122
Figure 70. Active Pharmaceutical Ingredients (API) Market in Mexico, 2022-2032, $ bn    124
Figure 71. Growth Stage of North America Active Pharmaceutical Ingredients (API) Industry over the Forecast Period    126
Figure 72. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022    133
Figure 73. AstraZeneca: Breakdown of Revenue by Region, 2022    133
Figure 74. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022    148
Figure 75. Boehringer Ingelheim: R&D Investement, 2019-2022    149
Selected Key Players:

AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)